Christopher Patusky serves as Executive at UNITED THERAPEUTICS CORP, where they oversee executive responsibilities. Since joining the company, Christopher Patusky has executed 203 insider transactions totaling $21.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 4, 2006 involved selling 4,000 shares valued at $220.4K.
Christopher Patusky currently holds 1,490 shares of UNITED THERAPEUTICS CORP (UTHR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Patusky has been a net seller of UTHR stock. They have purchased $2.4K and sold $21.3M worth of shares.
Christopher Patusky's most recent insider trade was on Aug 4, 2006, when they sold 4,000 shares at $55.09 per share.
Get notified when new Form 4 filings are submitted
| $23.27 |
| Discretionary |
| Aug 4, 2006 | UTHR | $32.6K | Option Exercise | 2,000 | $16.30 | Discretionary |